Corbus Pharmaceuticals Reports 2017 Third Quarter Financial Results and Highlights Recent Corporate and Clinical Advancements
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases,...
Marken Launches New App for Clinical Patients
Marken introduced the launch of a new online tool, Marken Viseo, which will allow patients to track their home deliveries of clinical trial materials...
INC Research/inVentiv Health to Present at Upcoming Jefferies 2017 London Healthcare Conference
INC Research/inVentiv Health (Nasdaq:INCR), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair Macdonald is scheduled to present at...
Servier Germany to co-promote Novartis’ blockbuster Entresto®
Servier Germany will start to co-promote Novartis’ potential blockbuster Entresto® (Sacubitril/Valsartan) used in cardiovascular diseases in Germany from November 1st 2017 onwards.
Servier was chosen...
Daiichi Sankyo Announces ENLIVEN Phase 3 Study of Pexidartinib Met Primary Endpoint in Tenosynovial Giant Cell Tumor
Daiichi Sankyo Company, Limited announced that the pivotal phase 3 placebo-controlled ENLIVEN (NCT02371369) study of pexidartinib met its primary endpoint of tumor response as...
Boehringer Ingelheim expands collaboration with Sarah Cannon Research Institute to investigate novel immuno-oncology combination therapy
Boehringer Ingelheim and Sarah Cannon Research Institute announced an expansion of their strategic partnership to bring innovative treatments to cancer patients by developing novel...
Cerus And Kedrion Biopharma Enter Distribution Agreement For The Full INTERCEPT Blood System Portfolio In Italy
Cerus Corporation announced that it has entered into an agreement with Kedrion Biopharma to distribute the full complement of INTERCEPT Blood System products in...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...